Search

everythinglearnresearchcommunity

for

Search:↓

Lupus can cause hair loss and nail changes, with treatments available for both.

Keratoacanthoma comes from hair follicle cells.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Transplanting hair follicles into chronic ulcers helps them heal better.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

The document corrects a name misspelling, acknowledges a pioneer in hair transplantation, and notes a missing conflict of interest disclosure.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Dermatology residents need thorough training in dermatosurgery for better patient outcomes.

EZH2 levels decrease as fetuses develop and are higher in adult skin, which may affect skin growth and repair.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

A rare benign skin nodule was found on the buttock, a unique location for this condition.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Children's skin diseases need special care and treatment.